Genmab A/S (GNMSF) Stock Research, Analysis & News

Quick Analysis on Genmab A/S (GNMSF) Stock as of January 29, 2020

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Genmab A/S (GNMSF) Stock below)

Genmab A/S (GNMSF) Stock Profile Summary

Genmab A/S, a biotechnology company, engages in the development of human antibody therapeutics for the potential treatment of cancer. The companys product pipeline includes Ofatumumab, a human monoclonal antibody for the treatment of in development for Chronic lymphocytic leukemia, non-Hodgkins lymphoma, diffuse large B-cell lymphoma, Waldenstroms macroglobulinemia, rheumatoid arthritis, and relapsing remitting multiple sclerosis; Zalutumumab, which is in Phase III clinical trials and targets the epidermal growth factor receptor; and Daratumumab, a human antibody to target the CD38 molecule expressed on the surface of multiple myeloma tumor cells. Its other clinical programs comprise RG4930 that is in Phase II development for asthma targeting OX40L; and RG1512 targeting P-selectin, which is in Phase I development stage for treatment of peripheral vascular diseases. In addition, the companys pre-clinical products comprise HuMax-CD32b, HuMax-TF, HuMax-VEGF, HuMax-Her2, and HuMax-Wnt for the treatment of cancer. It has collaboration agreements with Glaxo-SmithKline to co-develop and commercialize ofatumumab; Roche to conduct clinical studies with RG4930 and RG1512 antibodies; and Seattle Genetics Inc. to research an antibody-drug conjugate. The company was founded in 1999 and is based in Copenhagen, Denmark.

Genmab A/S (GNMSF) Stock Key Statistics Research and Analysis as of January 29, 2020

Mutual Funds with Genmab A/S (GNMSF) Stock in its top 10 holdings

FundCategoryGNMSF Holding Percentage
Artisan Global Opportunities InvWorld Stock3.02%
DFA Continental Small Company IEurope Stock0.8%
Fidelity Select Biotechnology PortfolioHealth1.97%
Fidelity Advisor Biotechnology AHealth1.66%
Henderson European Focus AEurope Stock2.98%

ETFs with Genmab A/S (GNMSF) Stock in its top 10 holdings

Latest Market News on Genmab A/S (GNMSF)

Click here to find the latest news on Genmab A/S (GNMSF)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center